SCHEMBL375076

SCHEMBL375076

Clc1cccc(CNC2CCOCC2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.56
PRMT6 Q96LA8 2/20 0.56
MAPT P10636 1/20 0.47
ALOX12 P18054 1/20 0.47
MAOB P27338 2/20 0.47
HTR6 P50406 2/20 0.47
MAP4K4 O95819 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.45
OPRL1 P41146 2/20 0.45
POLB P06746 2/20 0.45
CHRM2 P08172 1/20 0.45
ACHE P22303 2/20 0.44
BACE1 P56817 2/20 0.44
EPHX2 P34913 1/20 0.43
MEN1 O00255 1/20 0.43
BCHE P06276 1/20 0.43
KMT2A Q03164 1/20 0.43
TACR1 P25103 1/20 0.43
PRMT5 O14744 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64031 0.89 CARM1 (0.63) CARM1PRMT6MAPTALOX12ALDH1A1
Hydrochloric Acid SCHEMBL21879607 0.87 CARM1 (0.62) CARM1PRMT6MAPTALOX12ALDH1A1
SCHEMBL9667976 0.85 POLB (0.62) CARM1PRMT6MAPTALOX12ALDH1A1
SCHEMBL375144 0.83 POLB (0.46) CARM1PRMT6MAP4K4ALDH1A1MAPK1
SCHEMBL29577342 0.81 CARM1 (0.56) CARM1PRMT6MAPTALOX12ALDH1A1
SCHEMBL4586847 0.81 CARM1 (0.56) CARM1PRMT6MAPTALOX12MAOB
SCHEMBL382597 0.81 MAP4K4 (0.46) CARM1PRMT6MAP4K4ALDH1A1POLB
SCHEMBL28467365 0.81 CARM1 (0.56) CARM1PRMT6MAOBMAP4K4ALDH1A1
SCHEMBL17308302 0.81 ALDH1A1 (0.49) CARM1PRMT6MAP4K4ALDH1A1POLB
SCHEMBL15587413 0.81 ACHE (0.60) CARM1PRMT6MAOBMAP4K4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 CARM1 2663/4885PRMT6 2112/4885MAPT 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.